None listed
Conditions
Brief summary
Older people living in long-term care facilities (LTCFs) often experience medication-related problems. With the introduction of clinical pharmacists working on-site in Australian LTCFs, there is a need to support interprofessional collaboration and communication, and pharmacists’ impact on quality use of medicines. Medication Safety Needs Rounds build on the evidence-based principles of palliative care needs rounds. They involve an iterative monthly cycle to proactively identify residents at risk of medication-related harm, discuss these residents at an interprofessional triage meeting and implement follow-up actions to support quality use of medicines. This study aims to examine the feasibility and scalability of Medication Safety Need Rounds in LTCFs. Monthly Medication Safety Needs Rounds will be conducted in six LTCFs over six months. We will conduct a non-randomised mixed-methods feasibility study, guided by the Consolidated Framework for Implementation Research and key principles of feasibility studies, to answer the overarching question: ‘Can it work?’. Using a mixed-methods implementation and evaluation design, we will assess the feasibility of Medication Safety Needs Rounds on a small scale across multiple LTCFs, with a particular focus on the intervention acceptability, practicality, adaptation, integration into routine practice, implementation processes, demand, and associated resource requirements. We will also examine preliminary impacts on medication safety knowledge and skills, interprofessional communication/collaboration, and quality use of medicines indicators, while assessing the suitability of proposed outcome measures for future evaluation. A further objective is to evaluate the scalability of Medication Safety Needs Rounds across diverse LTCF contexts. Qualitative and quantitative data will be collected before, during and after implementation to evaluate the feasibility and scalability of the Medication Safety Needs Rounds. Study findings will be disseminated through a forum, plain language summaries, conference presentations and peer-reviewed publications.
Interventions
The Medication Safety Needs Rounds model is an interprofessional approach to improving medication safety in long-term care facilities (LTCFs). Medication Safety Needs Rounds involves a monthly cycle of identifying residents at risk of medication-related harm and conducting a triage meeting to discuss residents’ medication management needs, trigger subsequent actions and develop a plan, and then documenting meeting discussions and implementing follow-up actions. The interprofessional team meetings are designed as a triage meeting to facilitate a brief discussion of residents’ medication management needs among the team and interprofessional collaboration to proactively identify strategies to resolve medication-related issues. We will conduct a non-randomised mixed-methods feasibility study, guided by the Consolidated Framework for Implementation Research and key principles of feasibility studies, to answer the overarching question: ‘Can it work?’. This study will implement the Medication Safety Needs Rounds intervention across six LTCFs, with each LTCF conducting monthly meetings (approximately 1 hour in duration) for six months (i.e., 36 needs rounds overall). Each LTCF will be provided with a package of written implementation resources and tools that have been refined during a previous co-design study (1). The research team will provide hard and digital copies of the implementation package to each LTCF team (including the aged care on-site pharmacist, managers, nurses and general medical practitioners where appropriate) at the start of the implementation period. Aged care on-site pharmacists (ACOPs), and other health professionals, will be guided by the triggers identified in the Pocket Guide (provided in the co-designed implementation tools and resources package) to identify and prioritise approximately six to eight residents to discuss at each meeting. The Pocket Guide was informed by existing resources for prioritising individuals for clinical pharmacy services and monitoring medication management in LTCFs and refined during the co-design process. The triggers for identifying residents for discussion in the meeting are focused on changes in resident’s health and wellbeing, medication management issues, recent care transitions, and concerns from the resident, their family or supporters, and other health professionals. Health professionals using the Pocket Guide are expected to use their professional judgement and clinical expertise to screen, identify and select residents for the Medication Safety Needs Rounds meeting. The research team will work with members of each participating LTCF care team (e.g., managers, nurses, ACOPs, general medical practitioners (GPs)) to provide training and support prior to intervention commencement, and will embed regular opportunities for support and knowledge sharing throughout the study period (e.g., online drop-in sessions, phone and email communications). Training will focus on implementation and data collection processes, individuals’ roles, interprofessional communication/collaboration, communication with residents and their family or supporters, and use of the co-designed written implementation tools and resources. An online workshop (~2 hours) will be available for individuals involved or participating in Medication Safety Needs Rounds at each of the participating sites. An additional online workshop (~1.5 hours) will be available for ACOPs at each participating site. The training will be provided prior to the first Medication Safety Needs Rounds meeting at each site, and will be recorded and made available (together with accompanying slide decks) after the session. Pre-implementation engagement with participating LTCFs (e.g., online meetings and communication over email/telephone) will also develop an implementation plan with each site, including planning for study processes, data collection/reporting, site-specific flexibility, and strategies to engage GPs in needs rounds. The ACOPs will lead the Medication Safety Needs Rounds process and provide oversight of meeting preparation, documentation and completion of follow-up activities. In Australia, ACOPs are clinical pharmacists credentialled to work on-site in LTCFs. The ACOP role is grounded in provision of person-centred care (e.g., readily available, effective communication and collaboration with residents and supporters) and encompasses activities such as medication management (e.g., medication reconciliation, reviews), clinical governance (e.g., contributions to Medication Advisory Committees or other clinical governance structures), quality use of medicines (e.g., medication information, facility-wide quality improvement, education) and interprofessional communication and collaboration (e.g., multidisciplinary case conferences, care planning). Pre-meeting documentation (e.g., meeting agenda) will be circulated to needs rounds members prior to each meeting. ACOPs will be encouraged to ensure that each resident’s needs and preferences for medication management will be sought prior to the meeting via discussion with the resident and/or their supporter, and to follow-up with them after the meeting to facilitate shared decision-making. Members of the interprofessional Medication Safety Needs Rounds meeting may include the ACOPs, managers, GPs, nurses and personal care workers who administer medications, although the specific structure and representation of various roles and professions may vary between LTCFs (e.g., GP involvement). In each meeting, specific team members will be responsible for chairing the meeting and recording minutes, with guidance provided in the implementation materials. Documentation of action items and follow-up plans will be recorded using the co-designed templates. Follow-up actions triggered by the Medication Safety Needs Rounds meeting may include, for example, subsequent clinical work or support (e.g., case conference, comprehensive medication review, referral to allied health, specialist care or a support program, advanced care plan, lifestyle and wellbeing support, family meeting), changes to medication regimens (e.g., deprescribing, prescribing, supporting self-administration), staff education, or clinical governance activities (e.g., drug use evaluation, audit and feedback). Action plans will be documented after each meeting and followed up at the beginning of the next meeting to support the cyclical nature of the model. The needs rounds model supports the proactive identification and implementation of follow-up actions, interprofessional communication/collaboration, documentation, shared medication knowledge, and communication with residents and their families or supporters about medications. The model incorporates some flexibility to account for differences in practice between LTCFs and providers and this is reflected in the provision of guidance for some processes rather than specific requirements. Core components of the intervention include oversight and leadership by the ACOP, monthly interprofessional meetings focused on medication safety, and the development and documentation of action plans. Elements of flexibility can include the structure of GP involvement/attendance, documentation and reporting processes, intersection with other team meetings (including palliative care needs rounds), telehealth, and meeting attendees. Acknowledging some flexibility in the delivery between LTCFs ensures that it meets site-specific needs and this will be comprehensively evaluated to inform scale-up. This non-randomised feasibility study involves all participating LTCFs implementing the intervention, thus none are disadvantaged. De-identified documentation and tracking of Medication Safety Needs Rounds activities and resource utilisation data will be collected from each LTCF to assist assessment of adherence and fidelity, together with regular discussions and support between the sites and the research team during implementation. The description of this intervention adheres to the Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) checklist. 1. Hughes, GA, Javanparast, S, Davis, A, Gwilt, I, Yin, H, Little, K, Gutteridge, DS, Sluggett, JK, on behalf of the Medication Safety Needs Rounds Investigator Team. Resource pack to support implementation of Medication Safety Needs Rounds in long-term care facilities. Adelaide: Adelaide University; 2026. doi: https://doi.org/10.25909/32441520
Sponsors
Study design
Eligibility
Inclusion criteria
This intervention will be delivered at the long-term care facility (LTCF) level. This study does not have inclusion criteria at the resident level. LTCFs will be eligible if they have an aged care on-site pharmacist (ACOP) working in the LTCF for at least 6 months. The ACOP can be employed by the LTCF/long-term care provider, or the community pharmacy, in line with current policy for Australian Government funding that supports this role. Individuals participating in evaluation activities may include consumers, health professionals, LTCF staff, and other experts in medication management, aged care, research, or policy and/or practice planning and implementation. Individuals must be aged 18 years or over, able to speak English and have sufficient communication skills to share their experiences of providing or receiving care services. LTCF staff will assist the project team to ensure residents invited to participate are medically stable and able to provide informed consent, including verbally if required.
Exclusion criteria
This intervention will be delivered at the long-term care facility (LTCF) level and does not have exclusion criteria at the resident level. LTCFs without an aged care on-site pharmacist (ACOP), or where an ACOP has been working on-site for less than 6 months, will be ineligible. Individuals who are not medically stable and/or are unable to provide informed consent will not be eligible for participation in the evaluation activities.